Creating a new imaging system to improve cancer diagnosis
Official title: Development and evaluation of a combined X-ray transmission and diffraction imaging system for pathology
Funded at Quadridox, INC. · NIH-10925188 · Data updated 2026-11-12
This study is testing a new X-ray imaging system that helps doctors diagnose breast cancer more accurately and quickly, making it easier for patients to get their results without the usual delays.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Quadridox, INC. NIH-funded |
| Lab location | 1 site (Durham, United States) |
| Project start | September 8, 2023 |
| Project end | August 31, 2025 |
| Funding year | 2024 |
| Award (this year) | $923,685 |
| NIH project number | 5R44EB034645-02 |
| Project ID | NIH-10925188 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals undergoing surgical procedures for suspected breast cancer or other epithelial cancers.
✕Less likely to help
Patients with non-cancerous conditions or those not requiring surgical pathology evaluation may not benefit from this research.
What this research studies
This research focuses on developing an innovative X-ray diffraction imaging (XRDI) system to enhance the accuracy and efficiency of pathology in diagnosing cancers, particularly breast cancer. By utilizing XRDI, the research aims to eliminate subjective methods currently used in selecting tissue samples for analysis, which can lead to inconsistencies in diagnosis. The new technology seeks to reduce the time required for pathologists to analyze samples, potentially decreasing the wait time for patients to receive their diagnosis. This approach also aims to alleviate the workload on pathologists, allowing for more efficient processing of surgical specimens.
Why it matters
Potential benefit: If successful, this research could lead to faster and more accurate cancer diagnoses, improving patient outcomes and reducing the burden on healthcare systems.
How similar studies have gone: Other research has shown promise in using advanced imaging technologies for pathology, indicating that this approach could lead to significant advancements in cancer diagnosis.
Where this research is happening
-
Quadridox, INC.
Durham, United States Active
Researchers
- Principal investigator: Greenberg, Joel — Quadridox, INC.
- Study coordinator: Greenberg, Joel
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.